EGFR and HER-2/neu expression in gallbladder carcinoma: an institutional experience

ABSTRACT

Background: Gallbladder cancer [GBC] is the most common malignancy of the biliary tract in India. Despite the recent advancement in the understanding of the cancer biology, the disease still remains a therapeutic challenge with poor prognosis and low survival. Surgery is the primary modality of treatment and rest of the modalities are basically adjuvant in nature. This study was performed to evaluate the epidermal growth factor receptor [EGFR] and human epidermal growth factor receptor-2 [HER-2/neu] expression in GBC